1148 Projects
  • Missions
  • Kind of Research
  • Sector
  • Objective
  • Roadmaps
  • Key Enabling Technologies
  • Year

Optical biopsy using very short laser pulses

  • Central Mission: +5, -30 Doing much more against health inequalities
  • Mission I: Lifestyle and living environment
  • Mission II: Care in the living environment
  • Fundamental
We investigate the potential of ultrafast-spectroscopy for improved medical diagnostics using the fastest available light detector

Breathalyser-based Digital Biomarker for Alcohol Treatment

  • Central Mission: +5, -30 Doing much more against health inequalities
  • Mission I: Lifestyle and living environment
  • Mission II: Care in the living environment
  • Mission III: Participating with a disease or disability
A digital tool predicting alcohol relapse using clinical background, daily breathalyser samples and machine learning

KINDA (KINematic DBS Algorithm)

  • Central Mission: +5, -30 Doing much more against health inequalities
  • Mission II: Care in the living environment
  • Mission III: Participating with a disease or disability
  • Fundamental
AI-driven DBS for Parkinson’s: personalized, automated treatment using brain signals and video-based symptom tracking

Safe and effective immunotherapy for glioblastoma

  • Central Mission: +5, -30 Doing much more against health inequalities
  • Fundamental
  • Industrial
  • Healthcare
A novel, spatially-restricted, effective combinatorial CAR-T strategy to target GBM heterogeneity via nanobodies

A simple urine test to detect endometrial cancer

  • Central Mission: +5, -30 Doing much more against health inequalities
  • Mission II: Care in the living environment
  • Experimental
  • Healthcare
This project aims to identify novel DNA methylation markers in urine that distinguish women with endometrial cancer from those without. Using advanced technologies, we will develop a non-invasive, PCR-based urine test to improve early detection and reduce unnecessary diagnostic procedures in women with postmenopausal bleeding.

Pathological sensitivity of MRI biomarkers in Alzheimer’s disease

  • Central Mission: +5, -30 Doing much more against health inequalities
  • Mission II: Care in the living environment
  • Mission III: Participating with a disease or disability
  • Mission IV: Quality of life for people with dementia
How sensitive is MRI for underlying pathological mechanisms in Alzheimer’s disease?